Sharon Shacham
2017
In 2017, Sharon Shacham earned a total compensation of $2.5M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 83% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $171,856 |
---|---|
Option Awards | $1,857,650 |
Salary | $435,000 |
Other | $11,460 |
Total | $2,475,966 |
Shacham received $1.9M in option awards, accounting for 75% of the total pay in 2017.
Shacham also received $171.9K in non-equity incentive plan, $435K in salary and $11.5K in other compensation.
Rankings
In 2017, Sharon Shacham's compensation ranked 4,471st out of 14,666 executives tracked by ExecPay. In other words, Shacham earned more than 69.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,471 | 70th |
Manufacturing | 1,573 | 73rd |
Chemicals And Allied Products | 453 | 78th |
Drugs | 348 | 80th |
Pharmaceutical Preparations | 275 | 79th |
Shacham's colleagues
We found two more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2017.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019